Mitchell Mcleod Pugh & Williams Inc. Sells 874 Shares of Colgate-Palmolive (NYSE:CL)

Mitchell Mcleod Pugh & Williams Inc. lessened its stake in shares of Colgate-Palmolive (NYSE:CL) by 9.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,368 shares of the company’s stock after selling 874 shares during the quarter. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Colgate-Palmolive were worth $761,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of CL. Reston Wealth Management LLC bought a new position in Colgate-Palmolive during the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the third quarter worth approximately $53,000. Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $64,000. True Wealth Design LLC boosted its holdings in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC grew its position in Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after acquiring an additional 368 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the subject of several research analyst reports. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research report on Thursday. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. UBS Group decreased their price objective on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $101.11.

Colgate-Palmolive Stock Performance

NYSE CL opened at $88.79 on Monday. The firm has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm’s fifty day moving average price is $92.20 and its two-hundred day moving average price is $97.75. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.37% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.